Literature DB >> 24532467

NFKB1 -94 insertion/deletion polymorphism and cancer risk: a meta-analysis.

Linlin Xu1, Shaoyi Huang, Wei Chen, Zhichun Song, Shu Cai.   

Abstract

Previous studies on the associations of the NFKB1 -94 insertion/deletion polymorphism with cancer risk have produced conflicting results. The purpose of this meta-analysis is to define the effect of the NFKB1 -94 insertion/deletion polymorphism on cancer risk. A search of the literature by PubMed was performed to identify studies based on the predetermined inclusion criteria. Twenty-three studies consisting of 6,494 cases and 9,884 controls were identified and analyzed. Overall, significant association was observed between the polymorphism and cancer risk under all genetic models. Subgroup analysis according to ethnicity and cancer type also detected significant association. The NFKB1 -94 insertion/deletion polymorphism was associated with cancer risk in Asian population (dominant model: OR=1.52, 95 % CI=1.17-1.98; recessive model: OR=1.50, 95 % CI=1.26-1.79; II vs. DD: OR=1.90, 95 % CI=1.37-2.65; ID vs. DD: OR=1.32, 95 % CI=1.05-1.66; I vs. D: OR=1.37, 95 % CI=1.17-1.60), but not in Caucasian population. In addition, significant associations in OC, HCC, and OSCC were observed, but significant associations were not found in BC and LC. The current meta-analysis suggested that NFKB1 -94 insertion/deletion polymorphism may influence cancer risk in Asian population.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24532467     DOI: 10.1007/s13277-014-1672-z

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  32 in total

1.  Roles of functional NFKB1 and β-TrCP insertion/deletion polymorphisms in mRNA expression and epithelial ovarian cancer susceptibility.

Authors:  Z H Huo; H J Zhong; Y S Zhu; B Xing; H Tang
Journal:  Genet Mol Res       Date:  2013-03-11

2.  NFKB1 insertion/deletion promoter polymorphism increases the risk of advanced ovarian cancer in a Chinese population.

Authors:  Yaxin Fan; Weijian Yu; Ping Ye; Huali Wang; Zhongmin Wang; Qingli Meng; Ying Duan; Xiaohua Liang; Wanxin An
Journal:  DNA Cell Biol       Date:  2010-12-07       Impact factor: 3.311

3.  Functional polymorphism of NFKB1 promoter may correlate to the susceptibility of gastric cancer in aged patients.

Authors:  Su-Shun Lo; Jen-Hao Chen; Chew-Wun Wu; Win-Yiu Lui
Journal:  Surgery       Date:  2009-03       Impact factor: 3.982

4.  No association of the NF-kappaB1 -94ins/delATTG promoter polymorphism with relapse-free and overall survival in patients with squamous cell carcinomas of the head and neck region.

Authors:  G F Lehnerdt; A Bankfalvi; S Grehl; M Adamzik; S Lang; K W Schmid; W Siffert; K Riemann
Journal:  Int J Immunopathol Pharmacol       Date:  2008 Oct-Dec       Impact factor: 3.219

5.  Relationship between NFKB1 -94 insertion/deletion ATTG polymorphism and susceptibility of cervical squamous cell carcinoma risk.

Authors:  B Zhou; M Qie; Y Wang; L Yan; Z Zhang; A Liang; T Wang; X Wang; Y Song; L Zhang
Journal:  Ann Oncol       Date:  2009-11-05       Impact factor: 32.976

6.  A functional insertion/deletion polymorphism in the promoter region of NFKB1 gene increases susceptibility for nasopharyngeal carcinoma.

Authors:  Bin Zhou; Li Rao; Yi Li; Linbo Gao; Yanyun Wang; Yu Chen; Hui Xue; Yaping Song; Ying Peng; Miao Liao; Lin Zhang
Journal:  Cancer Lett       Date:  2008-11-08       Impact factor: 8.679

7.  Polymorphisms in NFkB, PXR, LXR and risk of colorectal cancer in a prospective study of Danes.

Authors:  Vibeke Andersen; Jane Christensen; Kim Overvad; Anne Tjønneland; Ulla Vogel
Journal:  BMC Cancer       Date:  2010-09-13       Impact factor: 4.430

8.  Hereditary risk factors for the development of gastric cancer in younger patients.

Authors:  Mohammad Yaghoobi; Naser Rakhshani; Farhad Sadr; Raheleh Bijarchi; Yasamin Joshaghani; Ashraf Mohammadkhani; Arezou Attari; Mohammad Reza Akbari; Mahshid Hormazdi; Reza Malekzadeh
Journal:  BMC Gastroenterol       Date:  2004-10-27       Impact factor: 3.067

9.  IkappaBalpha gene promoter polymorphisms are associated with hepatocarcinogenesis in patients infected with hepatitis B virus genotype C.

Authors:  Yongchao He; Hongwei Zhang; Jianhua Yin; Jiaxin Xie; Xiaojie Tan; Shijian Liu; Qian Zhang; Chengzhong Li; Jun Zhao; Hongyang Wang; Guangwen Cao
Journal:  Carcinogenesis       Date:  2009-10-01       Impact factor: 4.944

10.  Functional promoter -94 ins/del ATTG polymorphism in NFKB1 gene is associated with bladder cancer risk in a Chinese population.

Authors:  Pengchao Li; Jinbao Gu; Xiao Yang; Hongzhou Cai; Jun Tao; Xuejian Yang; Qiang Lu; Zengjun Wang; Changjun Yin; Min Gu
Journal:  PLoS One       Date:  2013-08-20       Impact factor: 3.240

View more
  7 in total

1.  The novel fusion transcript NR5A2-KLHL29FT is generated by an insertion at the KLHL29 locus.

Authors:  Zhenguo Sun; Xiquan Ke; Steven L Salzberg; Daehwan Kim; Valentin Antonescu; Yulan Cheng; Binbin Huang; Jee Hoon Song; John M Abraham; Sariat Ibrahim; Hui Tian; Stephen J Meltzer
Journal:  Cancer       Date:  2017-01-12       Impact factor: 6.860

2.  A functional insertion/deletion polymorphism in the promoter region of the NFKB1 gene increases the risk of papillary thyroid carcinoma.

Authors:  Xunli Wang; Hong Peng; Yundan Liang; Ruifen Sun; Tao Wei; Zhihui Li; Yanping Gong; Rixiang Gong; Feng Liu; Lin Zhang; Jingqiang Zhu
Journal:  Genet Test Mol Biomarkers       Date:  2015-02-18

3.  Genetic polymorphisms of IL-18 rs1946518 and IL-1β rs16944 are associated with prognosis and survival of acute myeloid leukemia.

Authors:  Hong Wang; Mingqiang Hua; Shukang Wang; Jie Yu; Chen Chen; Xueyun Zhao; Chen Zhang; Chaoqin Zhong; Ruiqing Wang; Na He; Ming Hou; Daoxin Ma
Journal:  Inflamm Res       Date:  2016-12-07       Impact factor: 4.575

4.  FEN1 -69G>A and 4150G>T polymorphisms and cancer risk in Chinese population.

Authors:  Xue-ren Gao; Shu-long Zhang; Yong-feng Yang; Guo-rong Han
Journal:  Sci Rep       Date:  2014-08-26       Impact factor: 4.379

5.  Distribution of allelic and genotypic frequencies of IL1A, IL4, NFKB1 and PAR1 variants in Native American, African, European and Brazilian populations.

Authors:  Marcos A T Amador; Giovanna C Cavalcante; Ney P C Santos; Leonor Gusmão; João F Guerreiro; Ândrea Ribeiro-dos-Santos; Sidney Santos
Journal:  BMC Res Notes       Date:  2016-02-16

6.  Analysis of 12 variants in the development of gastric and colorectal cancers.

Authors:  Giovanna C Cavalcante; Marcos At Amador; André M Ribeiro Dos Santos; Darlen C Carvalho; Roberta B Andrade; Esdras Eb Pereira; Marianne R Fernandes; Danielle F Costa; Ney Pc Santos; Paulo P Assumpção; Ândrea Ribeiro Dos Santos; Sidney Santos
Journal:  World J Gastroenterol       Date:  2017-12-28       Impact factor: 5.742

Review 7.  NFKB1 -94insertion/deletion ATTG polymorphism and cancer risk: Evidence from 50 case-control studies.

Authors:  Wen Fu; Zhen-Jian Zhuo; Yung-Chang Chen; Jinhong Zhu; Zhang Zhao; Wei Jia; Jin-Hua Hu; Kai Fu; Shi-Bo Zhu; Jing He; Guo-Chang Liu
Journal:  Oncotarget       Date:  2017-02-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.